Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Custom Media Event: ESG Summit
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Virtual Health
    • - Future of Healthcare Staffing
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
April 10, 2014 01:00 AM

High drug prices skewing payouts to some physicians

Joe Carlson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Ophthalmologists are among Medicare's highest paid specialists—a finding already drawing scrutiny from policymakers and watchdogs worried about waste and overuse. But doctors' advocates say the data shouldn't be interpreted as eye doctors getting rich off the government's senior citizen healthcare program.

    A closer inspection of the data reveals that many of the highest-paying codes for eye doctors relate to the use of Lucentis, a branded injectible drug for macular degeneration that costs $2,000 a dose.

    Medicare rules let doctors mark up the price of drugs delivered in their offices by 6% over the manufacturer's average sale price. The additional fee was designed to help physicians defray the cost of running their facilities.

    Ophthalmologists say the federal government's release of physician payment data has skewed public perception against them by including the total cost of drugs in overall Medicare payments. “Including those drug reimbursement dollars as part of a physician's Medicare payment artificially inflates the amount paid to ophthalmologists,” said Dr. David Park II, CEO of the American Academy of Ophthalmology in San Francisco.

    Related Content

    CMS reveals Medicare physician pay data

    Fla. eye doctor received almost $21 million from Medicare

    The federal government on Wednesday published an unprecedented database listing how much Medicare money was paid to some 880,000 doctors, broken down to the level of individual procedure code. The 9-million-line database only detailed Medicare Part B payments, which totaled about $77 billion in 2012.

    Not surprisingly, internists, who care for their patients from the office to the hospital bedside, received the most Medicare money as a group with $8.7 billion. But highly paid specialists like ophthalmologists drew the most attention because their outsized share of Medicare spending wouldn't seem to be justified by their relatively small numbers.

    The highest-paid Medicare doctor in the country is Florida ophthalmologist Salomon Melgen, who received $20.8 million from the government program in 2012. As a group, eye doctors received at least $5.6 billion—about 7% of total Medicare spending on physicians, making them the second-highest compensated group.

    Cardiologists received $5 billion, or 6% of the pie, making them the third-highest compensated specialty by Medicare.

    The relatively large amounts received by some specialties drew immediate fire from consumer groups. “If I was a policy maker, I would want to take a hard look at whether we are paying higher prices than we should for some of those procedures, or if there are excessive procedures being done,” said Robert Krughoff, president of Consumer's Checkbook, an advocacy group that has pushed for release of Part B data. “But I'd also want to take into account the way that things are reimbursed.”

    The reimbursements for several specialty groups reflect the price of drugs when they are delivered in physicians' offices. They include not just ophthalmologists but oncologists, whose practices deliver costly chemotherapy treatments.

    Nearly a decade ago, the government sought to limit the price paid for drugs through Medicare Part B by allowing them a 6% markup over the average sales price paid by physicians. The new system replaced the misnamed average wholesale price system, which congressional and HHS investigators repeatedly found was an arbitrarily high book price that was heavily discounted by drug companies to give physicians huge margins on drugs administered in their offices.

    Incentive to favor more expensive drugs

    While the new system succeeded in curbing excessive markups, it created a new incentive for physicians to favor more expensive drugs. A 6% markup grows in direct proportion to the retail price of the drug.

    For instance, ophthalmologists earn significantly higher markups by treating macular degeneration, a common malady among seniors, with Lucentis, which costs about $2,000 per treatment, instead of Avastin, which is equally effective and is made by the same company to treat cancer. Avastin can be administered for around $50 a treatment.

    Including the drug payments in the overall spending on physicians may also be skewing perceptions about whether services that involve drug administration can be more efficiently delivered in a doctor's office compared to a hospital, according to Sheryl Dacso, a partner in healthcare law at Seyfarth Shaw. “My speculation is that the cost would be higher when you add the professional fee and the facility charges for that same item or service,” she said, “but we don't have the data to make that comparison.”

    In a conference call with reporters Wednesday, a CMS official noted that the physician payment data don't allow the public to differentiate between the physician payment and drug payment when they are contained in a single Medicare Part B payment code.

    Follow Joe Carlson on Twitter: @MHJCarlson

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Supporting a truly diverse C-suite
    Supporting a truly diverse C-suite
    For top healthcare execs, leadership shapes legacy
    For top healthcare execs, leadership shapes legacy
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Transformation Summit
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Virtual Health
        • - Future of Healthcare Staffing
      • Custom Media Event: ESG Summit
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing